col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


105 Results       Page 1

 [1] 
Springer-Verlag: Annals of Hematology
  original article Date Title Authors   All Authors
1 [GO] 2024―Oct―23 Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms Nelson Luis Cahuapaza-Gutierrez
2 [GO] 2024―Sep―14 Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia Shuxia Zhang, Bangxiang Xie, Yanfang Lin, Chunrong Chen, Shu Yang, Shujuan Xu, et al. (+4)
3 [GO] 2024―Aug―31 Cold case: COVID-19-triggered type 1 cryoglobulinemia L.A.J. van Gils, M.F. Corsten, C.A. Koelman, R.J. Bosma, R. Fijnheer, A.H.L. Mulder, J.C. Regelink
4 [GO] 2024―Jul―16 Correction to: SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports Ryohei Ono, Izumi Kitagawa
5 [GO] 2024―Jul―15 Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia Christina-Nefeli Kontandreopoulou, Elena E. Solomou, Epaminondas Kolorizos, Panagiotis T. Diamantopoulos
6 [GO] 2024―Apr―23 SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports Ryohei Ono, Izumi Kitagawa
7 [GO] 2024―Apr―22 Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG) Huayuan Zhu, Xiao Lu, Xiaoping Zhang, Haiying Hua, Jie Zhang, Yuqing Miao, et al. (+23)
8 [GO] 2024―Apr―18 COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study Sophie Thau, Christian Bjørn Poulsen, Christian Brieghel, Morten Kranker Larsen, Lothar Wiese, Xiaohui Chen Nielsen, Lars Møller Pedersen
9 [GO] 2024―Mar―25 The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study Haixia Fu, Xuan Cai, Lijuan Cui, Weixia Nong, Wenqian Li, Heng Mei, et al. (+78)
10 [GO] 2024―Mar―04 Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies Patrick Reimann, Verena Petzer, Axel Mündlein, Bernd Hartmann, Luciano Severgnini, Alex Winkler, et al. (+16)
11 [GO] 2024―Feb―21 Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study Shuang Fan, Xiaodong Mo, Xiaohui Zhang, LanPing Xu, Yu Wang, Chenhua Yan, et al. (+11)
12 [GO] 2024―Feb―13 Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers Rasoul Ebrahimi, Fatemeh Nasri, Tahereh Kalantari
13 [GO] 2024―Jan―03 Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia Simona Leoni, Rayan Bou-Fakhredin, Francesca Granata, Elena Cassinerio, Marco Maggioni, Anna Ludovica Fracanzani, et al. (+2)
14 [GO] 2023―Dec―28 Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with acute leukemia Pengli Huang, Henghui Chang, Ruidong Zhang, Ying Wu, Peijing Qi, Yaguang Peng, et al. (+2)
15 [GO] 2023―Dec―14 Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study Ivo Demel, David Skopal, Eliška Šafránková, Petra Rozsívalová, Pavel Jindra, Jiří Šrámek, et al. (+12)
16 [GO] 2023―Nov―30 COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis Akbar Dorgalaleh, Ashkan Shabannezhad, Saeed Hassani
17 [GO] 2023―Nov―27 Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab Yuemin Gong, Xinyu Zhang, Xiaoyu Chen, Hui Yang, Yawen Zhang, Guangsheng He, Jianyong Li
18 [GO] 2023―Nov―11 Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, et al. (+8)
19 [GO] 2023―Oct―02 Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases Nicola Sgherza, Paola Curci, Rita Rizzi, Olga Battisti, Alberto Perfetto, Stefania Weigl, et al. (+4)
20 [GO] 2023―Aug―15 Association between ABO blood group/genotype and COVID-19 in a Japanese population Tatsuya Kusumoto, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka, Ho Lee, Shuhei Azekawa, et al. (+34)
21 [GO] 2023―Aug―14 Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era Feiyang Qi, Mei Bao, Hanlin Gao, Xiaoshuai Zhang, Shasha Zhao, Chenglei Wang, et al. (+2)
22 [GO] 2023―Jul―13 Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region Alessia Sticchi Damiani, Antonella Zizza, Federico Banchelli, Maddalena Gigante, Maria Lucia De Feo, Angelo Ostuni, et al. (+5)
23 [GO] 2023―Jul―12 Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease Qing He, Xuelin Dou, Yang Liu, Lei Wen, Fengrong Wang, Nan Peng, et al. (+7)
24 [GO] 2023―Jul―05 COVID-19 and β-thalassemia: in lieu of evidence and vague nexus Hayder M. Al-Kuraishy, Mohamed H. Mazhar Ashour, Hebatallah M. Saad, Gaber El-Saber Batiha
25 [GO] 2023―Jun―09 COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma Victoria R. Nachar, Anthony J. Perissinotti, Bernard L. Marini, Yasmin H. Karimi, Tycel J. Phillips
26 [GO] 2023―Apr―19 Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement Mohammad Sayyadi, Saeed Hassani, Mahmood Shams, Akbar Dorgalaleh
27 [GO] 2023―Apr―12 Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma Takashi Ishio, Shihori Tsukamoto, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Haruna Muraki, et al. (+4)
28 [GO] 2023―Apr―11 Gut microbiome alterations in patients with COVID-19-related coagulopathy Youli Chen, Xin Li, Cheng Yu, Erchuan Wang, Chang Luo, Yu Jin, et al. (+12)
29 [GO] 2023―Mar―26 G6PD deficiency-does it alter the course of COVID-19 infections? Tsz Yuen Au, Oskar Wojciech Wiśniewski, Shamiram Benjamin, Tadeusz Kubicki, Dominik Dytfeld, Lidia Gil
30 [GO] 2023―Mar―25 Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic Luca Guarnera, Elisa Buzzatti, Fabrizio Bonanni, Giovangiacinto Paterno, Antonella Riccitelli, Vittorio Forte, et al. (+2)
31 [GO] 2023―Mar―02 Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms Mirei Kobayashi, Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Hajime Senjo, Takashi Ishio, et al. (+8)
32 [GO] 2023―Feb―27 COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group Martin Šimkovič, Peter Turcsányi, Martin Špaček, Jana Mihályová, Pavlína Ryznerová, Mária Maco, et al. (+18)
33 [GO] 2023―Feb―16 Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins
34 [GO] 2022―Dec―10 BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2 Judith Konrat, Wiebke Rösler, Michael Roiss, Fabienne Meier-Abt, Corinne C. Widmer, Stefan Balabanov, et al. (+2)
35 [GO] 2022―Nov―24 Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain Ariana Ortuzar, María Laura Fox, Juan Antonio Vera, Álvaro Lorenzo Vizcaya, Alberto Marín Sánchez, Inmaculada Llopis Calatayud, et al. (+26)
36 [GO] 2022―Nov―18 CD19 CAR T-cell infusion during severe COVID-19 acute respiratory distress syndrome in large B-cell lymphoma Nina Buchtele, Philipp Wohlfarth, Thomas Staudinger, Peter Schellongowski, Ludwig Traby, Matthias Vossen, et al. (+5)
37 [GO] 2022―Nov―12 New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination Timothy Y. M. Ng, Winnie Z. Y. Teo, Terence Y. M. Ng, Gim Gee Teng
38 [GO] 2022―Oct―22 Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection Panagiotis T. Diamantopoulos, Christina-Nefeli Kontandreopoulou, Christos Stafylidis, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Maria Vardaka, et al. (+7)
39 [GO] 2022―Aug―26 Amyloidosis and COVID-19: experience from an amyloid program in Canada Ellen Lewis, Nowell Fine, Robert J. H. Miller, Christopher Hahn, Sameer Chhibber, Etienne Mahe, et al. (+6)
40 [GO] 2022―Aug―02 B-cell-guided strategy for SARS-CoV2 vaccination after autologous stem cell transplantation for B-cell lymphoma - a case report Ben-Niklas Baermann, Paul Jäger, Guido Kobbe
41 [GO] 2022―Jul―14 An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19 Hideaki Matsuura, Sumie Fujii, Yusuke Matsui, Yukari Sugiura, Hidehiko Akiyama, Yasuo Miura
42 [GO] 2022―Jul―14 Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies Ferenc Magyari, László Imre Pinczés, Edit Páyer, Katalin Farkas, Szilvia Ujfalusi, Ágnes Diószegi, et al. (+6)
43 [GO] 2022―Jul―08 Hemolytic anemia in COVID-19 Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ajeet Kaushik, Małgorzata Kujawska, Gaber El-Saber Batiha
44 [GO] 2022―Jul―02 Venous thromboembolism after COVID-19 mRNA vaccination Philip Murphy
45 [GO] 2022―Jul―02 Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients José Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, Rodrigo Martino, Lucia Lopez-Corral, María-José Terol, et al. (+26)
46 [GO] 2022―Jun―20 Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) Daniele Zama, Francesco Baccelli, Antonella Colombini, Amalia Contino, Elisabetta Calore, Maria Grazia Petris, et al. (+24)
47 [GO] 2022―May―24 SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness Malte B. Monin, Benjamin Marx, Lisa Meffert, Christoph Boesecke, Jürgen K. Rockstroh, Christian P. Strassburg, et al. (+2)
48 [GO] 2022―May―21 Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases Jil Rotterdam, Margot Thiaucourt, Christel Weiss, Juliana Schwaab, Andreas Reiter, Sebastian Kreil, et al. (+11)
49 [GO] 2022―Apr―11 COVID-19: impact of vaccination in myeloma patients E. Hoornaert, F. Dachy, A. Hansenne, S. Bailly, A. van Maanen, D. Gruson, M-C. Vekemans
50 [GO] 2022―Apr―07 Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies Ryutaro Taenaka, Teppei Obara, Kentaro Kohno, Kenichi Aoki, Ryosuke Ogawa
51 [GO] 2022―Mar―11 Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis Marko Lucijanic, Martina Demaria, Jelena Gnjidic, Zrinka Rob, Dora Filipovic, Toni Penovic, et al. (+9)
52 [GO] 2022―Feb―04 No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey Eriko Hamada, Kazuya Sakai, Shinya Yamada, Masayuki Kubo, Masaki Hayakawa, Masanori Matsumoto
53 [GO] 2022―Jan―27 Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination Ali Atoui, Kawthar Jarrah, Layal Al Mahmasani, Rayan Bou-Fakhredin, Ali T. Taher
54 [GO] 2021―Dec―04 Hemophagocytosis, hyper-inflammatory responses, and multiple organ damages in COVID-19-associated hyperferritinemia Guiying Dong, Jianbo Yu, Weibo Gao, Wei Guo, Jihong Zhu, Tianbing Wang
55 [GO] 2021―Oct―18 ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis Yen-Ching Wang, Tsung-Chih Chen, Chieh-Lin Jerry Teng, Cheng-Han Wu
56 [GO] 2021―Oct―13 Autologous hematopoietic stem cell transplantation with concomitant SARS-CoV-2 infection Hanna A. Knaus, W. Rabitsch, N. Buchtele, J. Cserna, P. Wohlfarth
57 [GO] 2021―Oct―01 Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination Kei Saito, Satoshi Ichikawa, Shunsuke Hatta, Yuna Katsuoka, Hideo Harigae, Tohru Izumi
58 [GO] 2021―Sep―24 Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India Anshul Gupta, Nihar Desai, Priyanka Chauhan, Soniya Nityanand, Zia Hashim, Mansi Gupta
59 [GO] 2021―Sep―22 Impact of rituximab on COVID-19 outcomes Hannah Levavi, Guido Lancman, Janice Gabrilove
60 [GO] 2021―Sep―17 Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil Evandro M. Fagundes, Naira N. Neto, Lorena M. Caldas, Jordana R. Aragão, Ana Beatriz F. Gloria, Leonardo G. Leite, et al. (+5)
61 [GO] 2021―Sep―13 Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue Robin Arcani, Julien Colle, Raphaël Cauchois, Marie Koubi, Pierre-André Jarrot, Rodolphe Jean, et al. (+8)
62 [GO] 2021―Aug―22 Association of blood type A with increased risk of severe COVID-19 in healthcare workers Niraj N. Mahajan, Rahul K. Gajbhiye, Periyasamy Kuppusamy, Shubhada Bahirat, Pradip D. Lokhande
63 [GO] 2021―Jul―26 Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience Marta Krejci, Ludek Pour, Zdenek Adam, Viera Sandecka, Martin Stork, Sabina Sevcikova, et al. (+3)
64 [GO] 2021―Jul―26 Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine Johannes Ruhe, Ulf Schnetzke, Karim Kentouche, Florian Prims, Michael Baier, Konstantin Herfurth, et al. (+4)
65 [GO] 2021―Jul―24 Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis Giovanni Caocci, Olga Mulas, Daniela Mantovani, Alessandro Costa, Andrea Galizia, Luca Barabino, et al. (+3)
66 [GO] 2021―May―25 Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals Can Boğa, Süheyl Asma, Göksel Leblebisatan, Nazan Şen, Anıl Tombak, Yusuf Ziya Demiroğlu, et al. (+8)
67 [GO] 2021―Mar―08 Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan
68 [GO] 2021―Feb―19 Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids Tien-Chan Hsieh, Oleg Sostin
69 [GO] 2021―Feb―02 Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy Irene Motta, Alessia Marcon, Maria Domenica Carrabba, Elena Cassinerio, Margherita Migone De Amicis, Adriana Branchi, et al. (+5)
70 [GO] 2021―Feb―01 Hematologic changes predict clinical outcome in recovered patients with COVID-19 Jian Mao, Rong Dai, Rui-Chan Du, Yan Zhu, Li-Ping Shui, Xiao-Hua Luo
71 [GO] 2021―Feb―01 COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications Layal Al Mahmasani, Mohammad Hassan Hodroj, Antoine Finianos, Ali Taher
72 [GO] 2021―Jan―18 HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19 Luca Roncati, Antonio Manenti, Luca Fabbiani, Claudia Malagoli, Vincenzo Nasillo, Beatrice Lusenti, et al. (+6)
73 [GO] 2021―Jan―07 Hematologic disorders associated with COVID-19: a review Mandeep Singh Rahi, Vishal Jindal, Sandra-Patrucco Reyes, Kulothungan Gunasekaran, Ruby Gupta, Ishmael Jaiyesimi
74 [GO] 2020―Nov―17 Questioning the association between ABO type and outcomes in patients with COVID-19 Jori E. May, Gerald McGwin, Radhika Gangaraju, Rita Paschal, Kaci Weaver, Jose L. O. Lima, Marisa B. Marques
75 [GO] 2020―Nov―13 Blood and platelet transfusion from a donor with presymptomatic Covid-19 Konstantinos Liapis, Menelaos Papoutselis, Georgios Vrachiolias, Christina Misidou, Emmanouil Spanoudakis, Zoe Bezirgiannidou, et al. (+3)
76 [GO] 2020―Nov―10 Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report Hannah Schüller, Franziska Klein, Michael Lübbert, Eric Peter Prager
77 [GO] 2020―Nov―07 COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry Maria Madeleine Rüthrich, C. Giessen-Jung, S. Borgmann, A. Y. Classen, S. Dolff, B. Grüner, et al. (+15)
78 [GO] 2020―Nov―06 Plasma hemoglobin in COVID-19: authors’ reply Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy
79 [GO] 2020―Oct―20 Characteristics of coagulation alteration in patients with COVID-19 Hong-chun Luo, Cheng-yan You, Si-wei Lu, Yue-qiang Fu
80 [GO] 2020―Oct―07 Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino
81 [GO] 2020―Sep―24 Elevated plasma hemoglobin in COVID-19-related illnesses: a critical appraisal Nishant R. Tiwari, Nagnath K. Redewad, Apurva A. Ketkar, Vivek R. Sharma
82 [GO] 2020―Sep―12 Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection Abdulrahman A. Algassim, Assem A. Elghazaly, Abdulrahman S. Alnahdi, Owais M. Mohammed-Rahim, Abdulaziz G. Alanazi, Nawaf A. Aldhuwayhi, et al. (+5)
83 [GO] 2020―Aug―28 High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19 Luca Roncati, Giuliano Bergonzini, Beatrice Lusenti, Vincenzo Nasillo, Ambra Paolini, Giuliana Zanelli, Stefania Corrado
84 [GO] 2020―Aug―17 Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience Ahmad Hanif, Sumera Khan, Nikhitha Mantri, Sana Hanif, Muhamed Saleh, Yamini Alla, et al. (+6)
85 [GO] 2020―Aug―01 Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19 Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy
86 [GO] 2020―Jul―18 COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan Xiang Zhou, Tao Bai, Katharina Meckel, Jun Song, Yu Jin, K. Martin Kortüm, et al. (+3)
87 [GO] 2020―Jul―18 Thrombocytopenia in COVID-19: pathophysiology matters Eleni Gavriilaki, Ioanna Sakellari, Maria Gavriilaki, Achilles Anagnostopoulos
88 [GO] 2020―Jul―12 Blood type and outcomes in patients with COVID-19 Christopher A. Latz, Charles DeCarlo, Laura Boitano, C. Y. Maximilian Png, Rushad Patell, Mark F. Conrad, et al. (+2)
89 [GO] 2020―Jun―29 Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments Yingying Wang, Jingfeng Li, Li Liu, Jianfang Li, Xiaoyan Liu, Jing He, et al. (+4)
90 [GO] 2020―Jun―26 SARS-CoV-2-associated cold agglutinin disease: a report of two cases Tessa Huscenot, Joris Galland, Margot Ouvrat, Mathias Rossignol, Stéphane Mouly, Damien Sène
91 [GO] 2020―Jun―25 IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection Carolina Villegas, María Poza, Paloma Talayero, José Manuel Caro Teller, Denis Zafra, Cristina Garcia, et al. (+9)
92 [GO] 2020―Jun―24 COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure Monia Marchetti
93 [GO] 2020―Jun―23 COVID-19, impact on myeloma patients Inès Dufour, Juliette Raedemaeker, Fabio Andreozzi, Géraldine Verstraete, Sarah Bailly, Michel Delforge, et al. (+13)
94 [GO] 2020―Jun―16 COVID-19 infection associated with autoimmune hemolytic anemia Antoine Capes, Sarah Bailly, Philippe Hantson, Ludovic Gerard, Pierre-François Laterre
95 [GO] 2020―Jun―13 COVID-19 presenting as neutropenic fever Hunter C. Spencer, Riana Wurzburger
96 [GO] 2020―Jun―13 SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone Giuseppe Visani, Martina Chiarucci, Barbara Guiducci, Maria Capalbo, Alessandro Isidori
97 [GO] 2020―Jun―12 SARS-CoV-2 infection in children with febrile neutropenia Victoria Flores, Raquel Miranda, Laura Merino, Carmen González, Cristina Serrano, Moises Solano, et al. (+6)
98 [GO] 2020―Jun―11 Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection Michele Merli, Walter Ageno, Fausto Sessa, Marco Salvini, Domenica Caramazza, Barbara Mora, et al. (+4)
99 [GO] 2020―Jun―04 Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report Zhiliang Hu, Wei Chen, Wenyan Liang, Chuanjun Xu, Wenkui Sun, Yongxiang Yi
100 [GO] 2020―Jun―03 Hematological findings in coronavirus disease 2019: indications of progression of disease Xiaoqing Liu, Run Zhang, Guangsheng He
101 [GO] 2020―May―27 Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19 Nil Albiol, Rahinatu Awol, Rodrigo Martino
102 [GO] 2020―May―24 Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease Luca Roncati, Beatrice Lusenti, Vincenzo Nasillo, Antonio Manenti
103 [GO] 2020―May―14 Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)? Giovanni Caocci, Giorgio La Nasa
104 [GO] 2020―May―08 Signals of Th2 immune response from COVID-19 patients requiring intensive care Luca Roncati, Vincenzo Nasillo, Beatrice Lusenti, Giovanni Riva
105 [GO] 2020―Apr―15 Mechanism of thrombocytopenia in COVID-19 patients Panyang Xu, Qi Zhou, Jiancheng Xu
 [1] 

105 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec